BioSpace News Archive

Ayala Pharmaceuticals, Inc. (Nasdaq: AYLA), a clinical-stage oncology company focused on developing and commercializing small molecule therapeutics for patients suffering from rare and aggressive cancers, primarily in genetically defined patient populations, today reported financial results for the first quarter ended March 31, 2021 and highlighted recent progress and upcoming milestones for its pipeline programs.

Misonix, Inc., a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative products that enhance clinical outcomes, announced its Board of Directors has appointed Patrick J. Beyer as an independent member of the Board.

Atreca, Inc., a biotechnology company focused on developing novel therapeutics generated through a unique discovery platform based on interrogation of the active human immune response, announced that it will present at the following upcoming virtual investor conferences

Reflects continued investment in driving consumer demand for Invisalign treatment through approximately 106,000 active Invisalign-trained doctors worldwide

Anticipate Emergency Use Submission for SARS-CoV-2 Antibody Biosensor Test in the Second Half of 2021

Odonate Therapeutics, Inc. (NASDAQ: ODT) today announced financial results for the three months ended March 31, 2021.

Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders characterized by neuronal imbalance, today announced that management will participate in the following upcoming virtual investor conferences:

New findings from an American College of Cardiology’s (ACC) survey revealed more than half of cardiologists (57%) believe patient preparation may lead to better quality discussions around treatment options for heart valve disease (HVD)

Increasing medical and healthcare data records on advent of efficient and smoother electronic health records is one of the key drivers for the growing global healthcare natural language processing market.

The demand within the global non-invasive ventilators market is set to increase at a sound pace in the times to follow.